logo

PTCT

Ptc Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

PTCT fundamentals

Ptc Therapeutics (PTCT) released its earnings on Nov 4, 2025: revenue was 211.00M (YoY +7.22%), beat estimates; EPS was 0.2 (YoY +114.39%), beat estimates.
Revenue / YoY
211.00M
+7.22%
EPS / YoY
0.2
+114.39%
Report date
Nov 4, 2025
PTCT Earnings Call Summary for Q3,2025
  • Sephience Breakthrough: $19.6M Q3 revenue, 521 U.S. starts, and 70% Phe reduction vs. BH4 highlight its potential as PKU standard of care.
  • Financial Confidence: Narrowed 2025 guidance to $750-800M, driven by Sephience and DMD resilience.
  • Pipeline Momentum: Votoplam HD program targeting Q4 FDA meeting for accelerated approval; $1.68B cash for M&A.
  • Global Growth: Japan, Brazil launches on track; 65% commercial payer mix stabilizing.
EPS
Revenue

Revenue & Expenses

PTCT has released its 2025 Q3 earnings report, with revenue of 211.01M, reflecting a YoY change of 7.23%, and net profit of 15.90M, showing a YoY change of 114.90%. The Sankey diagram below clearly presents PTCT's revenue sources and cost distribution.

Key Indicators

Ptc Therapeutics (PTCT) key financial stats and ratios, covering profitability, financial health, and leverage.
Ptc Therapeutics (PTCT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ptc Therapeutics (PTCT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ptc Therapeutics (PTCT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ptc Therapeutics (PTCT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ptc Therapeutics (PTCT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield